Detalhe da pesquisa
1.
Outcomes of a Phase II Study of Intraperitoneal Paclitaxel plus Systemic Capecitabine and Oxaliplatin (XELOX) for Gastric Cancer with Peritoneal Metastases.
Ann Surg Oncol
; 29(13): 8597-8605, 2022 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-36070113
2.
Low-Dose Nivolumab in Renal Cell Carcinoma: A Real-World Experience.
Oncology
; 99(3): 192-202, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-33440374
3.
ASO Visual Abstract: Outcomes of a Phase II Study of Intraperitoneal Paclitaxel Plus Systemic Capecitabine and Oxaliplatin (XELOX) for Gastric Cancer with Peritoneal Metastases.
Ann Surg Oncol
; 29(13): 8608-8609, 2022 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-36207480
4.
Bitten by a bug or a bag? Transfusion-transmitted dengue: a rare complication in the bleeding surgical patient.
Transfusion
; 55(7): 1655-61, 2015 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-25728040
5.
Real-world outcomes from use of CDK4/6 inhibitors in the management of advanced/metastatic breast cancer in Asia.
Ther Adv Med Oncol
; 14: 17588359221139678, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-36570409
6.
Atypical Response Patterns in Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors-Navigating the Radiologic Potpourri.
Cancers (Basel)
; 13(7)2021 Apr 02.
Artigo
Inglês
| MEDLINE | ID: mdl-33918397
7.
Immune checkpoint inhibition for non-small cell lung cancer in patients with pulmonary tuberculosis or Hepatitis B: Experience from a single Asian centre.
Lung Cancer
; 146: 145-153, 2020 08.
Artigo
Inglês
| MEDLINE | ID: mdl-32540557